ASIAN GINSENG

ASIAN GINSENG was reported 422 times

ASIAN GINSENG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 23 0.1769
1 APPENDICOLITH 58 0.1499
2 SLEEP DISORDER THERAPY 29 0.1465
3 ANALGESIC THERAPY 33 0.1028
4 DRUG THERAPY 32 0.0944
5 CONGENITAL HIATUS HERNIA 21 0.0921
6 MALIGNANT MELANOMA STAGE 0 17 0.0813
7 CARBUNCLE 23 0.0813
8 ANTICOAGULANT THERAPY 23 0.0810
9 BACTEROIDES INFECTION 18 0.0690
10 PHRENIC NERVE INJURY 1 0.0500
11 NEUROLOGICAL COMPLICATION ASSOCIATED WITH DEVICE 1 0.0323
12 MONOCLONAL IMMUNOGLOBULIN PRESENT 23 0.0303
13 BENIGN OESOPHAGEAL NEOPLASM 1 0.0286
14 DISLOCATION OF VERTEBRA 62 0.0272
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 54 0.0260
16 WRIST DEFORMITY 15 0.0244
17 CYP2D6 POLYMORPHISM 1 0.0227
18 HYPERPHOSPHATAEMIA 48 0.0223
19 PROGESTERONE ABNORMAL 1 0.0222
20 RED BLOOD CELL BURR CELLS PRESENT 1 0.0222
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 19 0.0205
22 BLOOD PHOSPHORUS INCREASED 54 0.0198
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
24 HYPOTHALAMO-PITUITARY DISORDER 23 0.0158
25 TOTAL LUNG CAPACITY DECREASED 24 0.0150
26 CEREBRAL VENTRICLE COLLAPSE 1 0.0133
27 MEAN PLATELET VOLUME ABNORMAL 1 0.0125
28 RHEUMATOID FACTOR POSITIVE 67 0.0116
29 C-REACTIVE PROTEIN ABNORMAL 68 0.0106
30 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 65 0.0091
31 BLOOD URIC ACID INCREASED 52 0.0090
32 GRIP STRENGTH 2 0.0087
33 FACET JOINT SYNDROME 28 0.0086
34 LIVER FUNCTION TEST 1 0.0085
35 IRON DEFICIENCY 38 0.0084
36 SWOLLEN JOINT COUNT 2 0.0080
37 LUNG OPACITY 21 0.0080
38 LIP DRY 68 0.0075
39 FIBROSIS 23 0.0075
40 AORTIC STENOSIS 26 0.0075
41 MYASTHENIA GRAVIS 60 0.0074
42 CRYPTITIS 1 0.0072
43 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 36 0.0071
44 PERIPHERAL VENOUS DISEASE 29 0.0071
45 HYPOPHOSPHATAEMIA 52 0.0070
46 APPENDICITIS 59 0.0063
47 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 106 0.0062
48 SERONEGATIVE ARTHRITIS 7 0.0061
49 MANIC SYMPTOM 1 0.0060
50 MULTIFOCAL MOTOR NEUROPATHY 1 0.0057
51 BONE EROSION 20 0.0056
52 LUPUS VULGARIS 7 0.0056
53 PLEURITIC PAIN 15 0.0054
54 HAND DEFORMITY 71 0.0054
55 HELICOBACTER INFECTION 55 0.0053
56 VENTRICULAR FIBRILLATION 59 0.0053
57 RESPIRATORY SYMPTOM 15 0.0053
58 JOINT RANGE OF MOTION DECREASED 70 0.0052
59 PEMPHIGUS 65 0.0052
60 BREAST CANCER STAGE II 43 0.0052
61 FINGER DEFORMITY 25 0.0052
62 DEAFNESS PERMANENT 1 0.0051
63 X-RAY ABNORMAL 9 0.0050
64 ILIUM FRACTURE 1 0.0049
65 SYNOVITIS 87 0.0048
66 MERALGIA PARAESTHETICA 1 0.0047
67 SWOLLEN JOINT COUNT INCREASED 15 0.0047
68 DYSLIPIDAEMIA 23 0.0045
69 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
70 OVERWEIGHT 23 0.0043
71 INJECTION SITE NERVE DAMAGE 1 0.0042
72 ASPARTATE AMINOTRANSFERASE 1 0.0041
73 TROPONIN INCREASED 30 0.0039
74 CARDIOGENIC SHOCK 55 0.0038
75 DUODENAL ULCER PERFORATION 28 0.0038
76 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
77 MUSCLE INJURY 31 0.0037
78 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
79 JEALOUS DELUSION 1 0.0035
80 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
81 BLOOD CALCIUM INCREASED 30 0.0034
82 BREAST CANCER STAGE III 22 0.0034
83 RHEUMATIC FEVER 15 0.0034
84 POLYCHROMASIA 1 0.0033
85 BUTTOCK INJURY 1 0.0033
86 GLOSSODYNIA 72 0.0032
87 SKIN OPERATION 1 0.0032
88 BREATH SOUNDS ABNORMAL 15 0.0030
89 PULMONARY FIBROSIS 57 0.0030
90 PSEUDOSTROKE 1 0.0029
91 RENAL CYST 23 0.0029
92 RETINITIS 5 0.0029
93 LIGAMENT OPERATION 1 0.0029
94 BACK DISORDER 47 0.0029
95 TENOPLASTY 1 0.0029
96 ANION GAP DECREASED 1 0.0029
97 OVERLAP SYNDROME 2 0.0029
98 PRESCRIBED OVERDOSE 55 0.0028
99 HYPOCHOLESTEROLAEMIA 1 0.0028
100 BURNING SENSATION MUCOSAL 1 0.0028
101 FOLLICULITIS 29 0.0028
102 BACTERIAL INFECTION 49 0.0026
103 PUSTULAR PSORIASIS 9 0.0026
104 PURPURA 23 0.0026
105 OESOPHAGEAL INJURY 1 0.0026
106 URINARY CASTS 1 0.0026
107 PRESCRIBED UNDERDOSE 51 0.0026
108 CONVULSIVE THRESHOLD LOWERED 1 0.0025
109 HYPERCHOLESTEROLAEMIA 24 0.0025
110 NEPHROPATHY 23 0.0025
111 HYPERLIPIDAEMIA 29 0.0024
112 LOWER LIMB FRACTURE 45 0.0023
113 BURSITIS 28 0.0023
114 EYELID INFECTION 1 0.0023
115 WOUND 63 0.0023
116 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
117 BODY HEIGHT DECREASED 23 0.0021
118 NEURALGIA 52 0.0021
119 ULCER 34 0.0021
120 BLOOD TEST ABNORMAL 30 0.0021
121 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
122 LOWER RESPIRATORY TRACT INFECTION 96 0.0021
123 SHOCK HYPOGLYCAEMIC 1 0.0021
124 ASCITES 58 0.0020
125 STOMA COMPLICATION 2 0.0020
126 JOINT DESTRUCTION 3 0.0019
127 GOUT 34 0.0019
128 SCIATICA 30 0.0019
129 RASH VESICULAR 9 0.0019
130 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
131 ASPIRATION 20 0.0018
132 OBESITY 29 0.0018
133 FIBROMYALGIA 44 0.0018
134 END STAGE RENAL DISEASE 33 0.0018
135 FOOT DEFORMITY 20 0.0018
136 REPETITIVE SPEECH 1 0.0018
137 RENAL TUBULAR DYSFUNCTION 1 0.0018
138 GAIT INABILITY 59 0.0018
139 BLOOD CHOLESTEROL INCREASED 80 0.0017
140 LIVER INJURY 42 0.0017
141 GRIP STRENGTH DECREASED 15 0.0017
142 LIVER DISORDER 75 0.0017
143 DIAPHRAGMATIC PARALYSIS 1 0.0017
144 PERICARDITIS 28 0.0017
145 SACRAL PAIN 1 0.0016
146 NEURODEGENERATIVE DISORDER 1 0.0016
147 DELIRIUM 56 0.0016
148 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
149 FULL BLOOD COUNT ABNORMAL 17 0.0016
150 ANAL INFLAMMATION 1 0.0016
151 ARTHROPATHY 87 0.0016
152 MUSCULOSKELETAL PAIN 82 0.0016
153 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
154 CELLULITIS STAPHYLOCOCCAL 1 0.0015
155 PERSONAL RELATIONSHIP ISSUE 1 0.0015
156 MICTURITION URGENCY 17 0.0015
157 SPINAL FUSION SURGERY 6 0.0015
158 ECHOCARDIOGRAM ABNORMAL 2 0.0014
159 DRUG TOLERANCE DECREASED 4 0.0014
160 HEPATIC ENZYME INCREASED 97 0.0014
161 PORPHYRIA ACUTE 2 0.0014
162 PARASOMNIA 1 0.0014
163 SUSPECTED OFF LABEL USE 6 0.0013
164 OSTEOARTHRITIS 56 0.0013
165 PSORIATIC ARTHROPATHY 53 0.0013
166 DEBRIDEMENT 1 0.0013
167 MYASTHENIC SYNDROME 1 0.0013
168 OEDEMA 69 0.0013
169 IRRITABLE BOWEL SYNDROME 27 0.0013
170 GOUTY ARTHRITIS 1 0.0013
171 DISCOMFORT 76 0.0012
172 HAPTOGLOBIN DECREASED 1 0.0012
173 HEPATIC STEATOSIS 23 0.0012
174 WALKING AID USER 8 0.0012
175 LIVER FUNCTION TEST INCREASED 26 0.0012
176 EPILEPSY 37 0.0012
177 RALES 7 0.0012
178 GENERAL SYMPTOM 9 0.0012
179 FLUID RETENTION 61 0.0012
180 LUNG OPERATION 1 0.0012
181 MEAN PLATELET VOLUME DECREASED 1 0.0012
182 SOLILOQUY 1 0.0012
183 HYPONATRAEMIA 65 0.0012
184 NAIL DISORDER 10 0.0011
185 BLEPHAROSPASM 7 0.0011
186 JOINT STIFFNESS 29 0.0011
187 WOUND INFECTION 12 0.0011
188 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
189 PREMATURE MENOPAUSE 1 0.0011
190 LUNG DISORDER 53 0.0011
191 C-REACTIVE PROTEIN 1 0.0011
192 CATHETER SITE SWELLING 1 0.0011
193 GENERAL PHYSICAL HEALTH DETERIORATION 123 0.0011
194 INJURY 74 0.0011
195 ROAD TRAFFIC ACCIDENT 44 0.0011
196 WRONG SCHEDULE 1 0.0010
197 PARTNER STRESS 1 0.0010
198 RED BLOOD CELL ABNORMALITY 1 0.0010
199 BRONCHIECTASIS 7 0.0010
200 DRY MOUTH 84 0.0010
201 DRUG INTOLERANCE 100 0.0010
202 ANIMAL SCRATCH 1 0.0010
203 INFUSION SITE REACTION 3 0.0010
204 MYOSITIS 9 0.0010
205 INFUSION RELATED REACTION 66 0.0010
206 MUSCULOSKELETAL STIFFNESS 87 0.0010
207 DIABETES MELLITUS 75 0.0010
208 IRON DEFICIENCY ANAEMIA 9 0.0010
209 CHANGE OF BOWEL HABIT 2 0.0010
210 SLEEP DISORDER 68 0.0010
211 SLEEP DEFICIT 2 0.0009
212 PANCREATIC MASS 1 0.0009
213 NIGHT SWEATS 30 0.0009
214 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 6 0.0009
215 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
216 POST PROCEDURAL SWELLING 1 0.0009
217 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 47 0.0009
218 SWELLING 84 0.0009
219 LIMB INJURY 24 0.0009
220 EXOSTOSIS 8 0.0009
221 PROCALCITONIN INCREASED 1 0.0009
222 SENSE OF OPPRESSION 1 0.0008
223 AMNESIA 55 0.0008
224 REFLUX GASTRITIS 1 0.0008
225 BLEEDING TIME PROLONGED 1 0.0008
226 SPONDYLITIS 3 0.0008
227 IMPAIRED HEALING 27 0.0008
228 AUTOIMMUNE DISORDER 8 0.0008
229 EJECTION FRACTION ABNORMAL 1 0.0008
230 INFUSION SITE WARMTH 1 0.0008
231 MOVEMENT DISORDER 26 0.0008
232 HYPERVOLAEMIA 4 0.0008
233 MALIGNANT MELANOMA IN SITU 1 0.0008
234 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
235 JOINT INJURY 17 0.0008
236 DYSSTASIA 23 0.0008
237 STOMA SITE INFECTION 1 0.0008
238 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
239 TRANSAMINASES INCREASED 17 0.0008
240 OSTEOPOROSIS 31 0.0008
241 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
242 ULCER HAEMORRHAGE 5 0.0007
243 SPUTUM DISCOLOURED 7 0.0007
244 BONE DENSITY DECREASED 23 0.0007
245 STOMA SITE DISCHARGE 2 0.0007
246 DISCHARGE 1 0.0007
247 ONYCHOMADESIS 3 0.0007
248 CHOLELITHIASIS 23 0.0007
249 SKIN DISORDER 23 0.0007
250 THROMBOSIS 54 0.0007
251 INJECTION SITE PARAESTHESIA 1 0.0007
252 ABDOMINAL DISTENSION 67 0.0006
253 TASTE DISORDER 13 0.0006
254 URINE KETONE BODY PRESENT 1 0.0006
255 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
256 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
257 ILLUSION 1 0.0006
258 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
259 DYSPEPSIA 59 0.0006
260 CARDIOVASCULAR DISORDER 15 0.0006
261 INTENTIONAL PRODUCT MISUSE 51 0.0006
262 RHEUMATOID ARTHRITIS 66 0.0006
263 BLOOD CHLORIDE INCREASED 1 0.0006
264 SEPSIS 64 0.0006
265 POLYARTHRITIS 3 0.0006
266 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
267 CORONARY ARTERY DISEASE 17 0.0006
268 DISABILITY 11 0.0006
269 NORMAL NEWBORN 3 0.0006
270 LUPUS-LIKE SYNDROME 5 0.0006
271 CONTUSION 53 0.0005
272 SCLERODERMA 2 0.0005
273 PULMONARY EMBOLISM 52 0.0005
274 STOMATITIS 33 0.0005
275 WHEEZING 32 0.0005
276 JOINT SWELLING 65 0.0005
277 PULMONARY MASS 8 0.0005
278 STOMA SITE ERYTHEMA 1 0.0005
279 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
280 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
281 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
282 HIP ARTHROPLASTY 8 0.0005
283 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
284 OEDEMA PERIPHERAL 63 0.0005
285 BICYTOPENIA 1 0.0005
286 RENAL HAEMORRHAGE 1 0.0005
287 BLOOD CREATININE INCREASED 32 0.0005
288 PSYCHOTIC SYMPTOM 1 0.0005
289 INFLAMMATION 25 0.0005
290 LIVE BIRTH 4 0.0005
291 JOINT DISLOCATION 5 0.0005
292 CATHETER SITE ERYTHEMA 1 0.0005
293 HAEMOPTYSIS 13 0.0005
294 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
295 VITREOUS DETACHMENT 1 0.0005
296 BACK INJURY 5 0.0005
297 ONYCHOMYCOSIS 2 0.0005
298 TEMPERATURE REGULATION DISORDER 1 0.0004
299 BLISTER 25 0.0004
300 CONDITION AGGRAVATED 135 0.0004
301 PLEURAL EFFUSION 27 0.0004
302 ACUTE HEPATIC FAILURE 6 0.0004
303 CHEST PAIN 80 0.0004
304 YELLOW SKIN 2 0.0004
305 HEPATIC CIRRHOSIS 8 0.0004
306 LEARNING DISORDER 1 0.0004
307 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
308 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
309 PERSECUTORY DELUSION 1 0.0004
310 LABYRINTHITIS 1 0.0004
311 INFECTION 57 0.0004
312 KNEE ARTHROPLASTY 8 0.0004
313 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
314 ANIMAL BITE 1 0.0004
315 ABDOMINAL MASS 1 0.0004
316 ABDOMINAL PAIN 86 0.0004
317 ARTHRITIS 29 0.0004
318 MIGRAINE WITH AURA 1 0.0004
319 PROCTITIS 1 0.0004
320 ALOPECIA 70 0.0004
321 TYPE 2 DIABETES MELLITUS 12 0.0004
322 HYPERTENSION 75 0.0004
323 PRODUCT LABEL CONFUSION 2 0.0003
324 SOMNOLENCE 69 0.0003
325 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
326 NECK INJURY 1 0.0003
327 REBOUND ACID HYPERSECRETION 1 0.0003
328 EYE INJURY 1 0.0003
329 INFUSION SITE PRURITUS 1 0.0003
330 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
331 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
332 LISTLESS 1 0.0003
333 NEAR DEATH EXPERIENCE 1 0.0003
334 PSORIASIS 38 0.0003
335 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
336 GASTROINTESTINAL DISORDER 26 0.0003
337 CERVICAL VERTEBRAL FRACTURE 1 0.0003
338 HYPOPNOEA 1 0.0003
339 DRUG-INDUCED LIVER INJURY 9 0.0003
340 DEPRESSIVE SYMPTOM 1 0.0003
341 ANAEMIA 54 0.0003
342 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
343 HAEMORRHAGIC DIATHESIS 1 0.0003
344 CONSTIPATION 61 0.0003
345 HYPOAESTHESIA 41 0.0003
346 PRODUCT USE ISSUE 51 0.0003
347 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
348 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
349 THYROID MASS 1 0.0003
350 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
351 RHINOVIRUS INFECTION 1 0.0003
352 BRAIN FOG 4 0.0003
353 PROSTATOMEGALY 1 0.0003
354 NAIL DISCOLOURATION 1 0.0003
355 C-REACTIVE PROTEIN INCREASED 9 0.0002
356 ADRENAL INSUFFICIENCY 3 0.0002
357 PERIPHERAL SWELLING 38 0.0002
358 SPINAL STENOSIS 1 0.0002
359 ASTHMA 27 0.0002
360 ARTHRALGIA 99 0.0002
361 DECREASED APPETITE 55 0.0002
362 MUSCLE STRAIN 2 0.0002
363 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
364 GROIN PAIN 2 0.0002
365 HYPOXIA 8 0.0002
366 PHYSICAL DISABILITY 1 0.0002
367 BLOOD CREATINE INCREASED 1 0.0002
368 EAR INFECTION 6 0.0002
369 GAIT DISTURBANCE 43 0.0002
370 GASTROINTESTINAL INFECTION 2 0.0002
371 MENINGITIS ASEPTIC 1 0.0002
372 MOBILITY DECREASED 16 0.0002
373 RENAL FAILURE 29 0.0002
374 PNEUMONIA BACTERIAL 2 0.0002
375 BRAIN NEOPLASM 2 0.0002
376 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
377 ASTHENIA 81 0.0002
378 RENAL FUNCTION TEST ABNORMAL 1 0.0002
379 SEASONAL ALLERGY 3 0.0002
380 SKIN ABRASION 1 0.0002
381 VOMITING 98 0.0002
382 DIZZINESS POSTURAL 2 0.0002
383 EAR PAIN 4 0.0002
384 DYSPNOEA 116 0.0002
385 COELIAC DISEASE 2 0.0002
386 IMMUNODEFICIENCY 3 0.0002
387 RESPIRATORY DISORDER 6 0.0002
388 ABDOMINAL PAIN UPPER 41 0.0002
389 CORONARY ARTERY STENOSIS 1 0.0002
390 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
391 DRUG TOLERANCE 1 0.0002
392 PARAESTHESIA 31 0.0002
393 URTICARIA 33 0.0002
394 PERIPHERAL VASCULAR DISORDER 1 0.0002
395 LIMB DISCOMFORT 6 0.0002
396 POOR VENOUS ACCESS 2 0.0002
397 CONFUSIONAL STATE 31 0.0002
398 MEMORY IMPAIRMENT 26 0.0002
399 COMPRESSION FRACTURE 1 0.0002
400 ABDOMINAL DISCOMFORT 31 0.0002
401 SKIN LACERATION 2 0.0002
402 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
403 DEAFNESS UNILATERAL 1 0.0002
404 ILL-DEFINED DISORDER 11 0.0002
405 NAUSEA 143 0.0002
406 INJECTION SITE INJURY 1 0.0002
407 STREPTOCOCCAL INFECTION 1 0.0002
408 NASOPHARYNGITIS 33 0.0002
409 BLOOD CALCIUM DECREASED 2 0.0002
410 HYPERSENSITIVITY 33 0.0002
411 SKIN TOXICITY 1 0.0002
412 CARDIAC VALVE DISEASE 1 0.0002
413 MUSCLE SPASMS 32 0.0002
414 PARANOIA 3 0.0002
415 EXERCISE TOLERANCE DECREASED 1 0.0002
416 PRODUCT USE IN UNAPPROVED INDICATION 42 0.0002
417 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
418 WEIGHT INCREASED 37 0.0002
419 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
420 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
421 PYREXIA 56 0.0002
422 SCOLIOSIS 1 0.0002
423 SWELLING OF EYELID 1 0.0002
424 HYPOCALCAEMIA 3 0.0002
425 MIGRAINE 15 0.0002
426 THERAPY NON-RESPONDER 7 0.0002
427 INCOHERENT 1 0.0002
428 APPLICATION SITE VESICLES 1 0.0002
429 NODULE 2 0.0002
430 HYPOGAMMAGLOBULINAEMIA 1 0.0002
431 BEDRIDDEN 2 0.0002
432 PULMONARY CONGESTION 2 0.0002
433 PRODUCT FORMULATION ISSUE 1 0.0002
434 CORONAVIRUS INFECTION 1 0.0002
435 APPETITE DISORDER 1 0.0002
436 ADVERSE REACTION 2 0.0002
437 PREGNANCY 3 0.0001
438 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
439 IMPAIRED GASTRIC EMPTYING 2 0.0001
440 EYE MOVEMENT DISORDER 1 0.0001
441 TREATMENT FAILURE 12 0.0001
442 HYPERTRANSAMINASAEMIA 1 0.0001
443 RASH MACULAR 5 0.0001
444 APPLICATION SITE REACTION 1 0.0001
445 BACK PAIN 33 0.0001
446 IMPAIRED QUALITY OF LIFE 2 0.0001
447 MAJOR DEPRESSION 1 0.0001
448 SINUSITIS 14 0.0001
449 OFF LABEL USE 119 0.0001
450 CEREBRAL DISORDER 1 0.0001
451 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
452 ECONOMIC PROBLEM 2 0.0001
453 INSURANCE ISSUE 2 0.0001
454 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
455 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
456 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
457 HYPOALBUMINAEMIA 1 0.0001
458 MULTIPLE ALLERGIES 1 0.0001
459 FATIGUE 97 0.0001
460 RHINITIS 1 0.0001
461 STENT PLACEMENT 1 0.0001
462 POST PROCEDURAL INFECTION 1 0.0001
463 ADVERSE DRUG REACTION 11 0.0001
464 MANIA 2 0.0001
465 ACUTE CORONARY SYNDROME 1 0.0001
466 EOSINOPHIL COUNT INCREASED 1 0.0001
467 INFUSION SITE ERYTHEMA 1 0.0001
468 HEPATITIS 3 0.0001
469 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
470 MUSCULAR WEAKNESS 13 0.0001
471 MALAISE 50 0.0001
472 PRODUCT COMMUNICATION ISSUE 1 0.0001
473 DRUG ERUPTION 2 0.0001
474 PNEUMONIA 36 0.0001
475 LOSS OF LIBIDO 1 0.0001
476 FREQUENT BOWEL MOVEMENTS 3 0.0001
477 GASTROENTERITIS VIRAL 2 0.0001
478 SKIN LESION 3 0.0001
479 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
480 TREMOR 18 0.0001
481 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
482 NECK PAIN 6 0.0001
483 EYE PAIN 6 0.0001
484 DYSPNOEA EXERTIONAL 4 0.0001
485 BLOOD SODIUM DECREASED 2 0.0001
486 SPINAL DISORDER 1 0.0001
487 FALL 35 0.0001
488 RECALLED PRODUCT ADMINISTERED 1 0.0001
489 PRODUCTIVE COUGH 5 0.0001
490 ATELECTASIS 1 0.0001
491 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
492 CHOKING 2 0.0001
493 VITREOUS FLOATERS 1 0.0001
494 BLADDER DISORDER 1 0.0001
495 BLOOD PRESSURE ABNORMAL 2 0.0001
496 SALIVARY HYPERSECRETION 1 0.0001
497 BRAIN INJURY 1 0.0001
498 HYPOTHERMIA 1 0.0001
499 TOOTH ABSCESS 1 0.0001
500 BODY TEMPERATURE INCREASED 2 0.0001
501 ADVERSE EVENT 9 0.0001
502 TEMPERATURE INTOLERANCE 1 0.0001
503 EYE DISCHARGE 1 0.0001
504 TENDERNESS 1 0.0001
505 PRODUCT QUALITY ISSUE 13 0.0001
506 WEIGHT FLUCTUATION 1 0.0001
507 TRANSFUSION 1 0.0001
508 PRODUCT DOSE OMISSION ISSUE 28 0.0001
509 INJECTION SITE DISCOMFORT 1 0.0001
510 SUDDEN DEATH 1 0.0001
511 PAIN 58 0.0001
512 OESOPHAGITIS 1 0.0001
513 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
514 BLOOD GLUCOSE FLUCTUATION 1 0.0001
515 COLITIS ULCERATIVE 4 0.0001
516 SKIN INFECTION 1 0.0001
517 OCULAR DISCOMFORT 1 0.0001
518 APPLICATION SITE PRURITUS 2 0.0001
519 SCAB 1 0.0001
520 HAEMATURIA 3 0.0001
521 NEOPLASM 1 0.0001
522 HYPOKALAEMIA 4 0.0001
523 SEXUAL DYSFUNCTION 1 0.0001
524 COVID-19 PNEUMONIA 1 0.0001
525 OCULAR HYPERAEMIA 4 0.0001
526 BLOOD IRON DECREASED 1 0.0001
527 MACULAR DEGENERATION 1 0.0001
528 BLOOD PRESSURE FLUCTUATION 2 0.0001
529 RESPIRATORY DEPRESSION 1 0.0001
530 MUSCLE SPASTICITY 1 0.0001
531 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
532 GENERALISED OEDEMA 1 0.0001
533 RASH 35 0.0001
534 DIZZINESS 40 0.0001
535 WEIGHT DECREASED 22 0.0001
536 TACHYCARDIA 7 0.0001
537 DRUG INEFFECTIVE 103 0.0001
538 ERECTILE DYSFUNCTION 2 0.0001
539 DIPLOPIA 2 0.0001
540 TOOTH INFECTION 1 0.0001
541 QUALITY OF LIFE DECREASED 1 0.0001
542 PROCEDURAL PAIN 2 0.0001
543 HUNGER 1 0.0001
544 HEADACHE 45 0.0001
545 DEMENTIA 2 0.0001
546 CARPAL TUNNEL SYNDROME 1 0.0001
547 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
548 SUBDURAL HAEMATOMA 1 0.0001
549 HYPERSOMNIA 2 0.0001
550 LETHARGY 4 0.0001
551 EYE IRRITATION 4 0.0001
552 PARAESTHESIA ORAL 1 0.0001
553 MYELODYSPLASTIC SYNDROME 1 0.0001
554 SEPTIC SHOCK 3 0.0001
555 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
556 NASAL CONGESTION 4 0.0001
557 PSYCHOTIC DISORDER 2 0.0001
558 BRONCHITIS 5 0.0001
559 HYPOAESTHESIA ORAL 1 0.0001
560 LACRIMATION INCREASED 2 0.0001
561 DIARRHOEA 42 0.0001
562 ANKLE FRACTURE 1 0.0001
563 PAIN IN EXTREMITY 19 0.0001
564 EXPOSURE DURING PREGNANCY 4 0.0001
565 EJECTION FRACTION DECREASED 1 0.0001
566 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
567 PNEUMOTHORAX 1 0.0001
568 ABSCESS 1 0.0001
569 SYNCOPE 6 0.0001
570 AGGRESSION 3 0.0001
571 URINARY RETENTION 2 0.0001
572 BLOOD UREA INCREASED 1 0.0001
573 CELLULITIS 3 0.0001
574 ORTHOSTATIC HYPOTENSION 1 0.0001
575 DEVICE USE ISSUE 1 0.0001
576 COUGH 16 0.0001
577 COLD SWEAT 1 0.0001
578 VISUAL IMPAIRMENT 7 0.0001
579 HEAD DISCOMFORT 1 0.0001
580 TREATMENT NONCOMPLIANCE 3 0.0001
581 ACCIDENTAL OVERDOSE 2 0.0001
582 LOSS OF CONSCIOUSNESS 7 0.0001
583 BLOOD GLUCOSE ABNORMAL 1 0.0001
584 MEDICATION ERROR 3 0.0001
585 THINKING ABNORMAL 1 0.0001
586 DEATH 46 0.0001
587 PHOTOPHOBIA 1 0.0001
588 PROTEINURIA 1 0.0001
589 INCREASED APPETITE 1 0.0001
590 SEROTONIN SYNDROME 1 0.0001
591 SEIZURE 6 0.0001
592 BONE PAIN 3 0.0001
593 KIDNEY INFECTION 1 0.0001
594 SINUS DISORDER 1 0.0001
595 UPPER LIMB FRACTURE 1 0.0001
596 PRURITUS 19 0.0000
597 NEUTROPHIL COUNT DECREASED 2 0.0000
598 FEELING HOT 3 0.0000
599 EATING DISORDER 1 0.0000
600 IMPAIRED WORK ABILITY 1 0.0000
601 RECTAL HAEMORRHAGE 2 0.0000
602 POOR QUALITY SLEEP 1 0.0000
603 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
604 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
605 BLOOD PRESSURE INCREASED 7 0.0000
606 APPLICATION SITE PAIN 1 0.0000
607 CHROMATURIA 1 0.0000
608 HEART RATE IRREGULAR 1 0.0000
609 VISION BLURRED 6 0.0000
610 MUSCLE TWITCHING 1 0.0000
611 OROPHARYNGEAL PAIN 4 0.0000
612 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
613 CARDIAC DISORDER 4 0.0000
614 DISEASE PROGRESSION 5 0.0000
615 ARRHYTHMIA 2 0.0000
616 THERAPY INTERRUPTED 3 0.0000
617 PRESYNCOPE 1 0.0000
618 UNDERDOSE 3 0.0000
619 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
620 DRY EYE 2 0.0000
621 DEPRESSION 9 0.0000
622 ABDOMINAL PAIN LOWER 1 0.0000
623 HYPOPHAGIA 1 0.0000
624 ILLNESS 4 0.0000
625 HYPERHIDROSIS 5 0.0000
626 SKIN ULCER 1 0.0000
627 ANXIETY 11 0.0000
628 DEAFNESS 1 0.0000
629 SEDATION 1 0.0000
630 APPLICATION SITE ERYTHEMA 1 0.0000
631 ANHEDONIA 1 0.0000
632 DEPRESSED MOOD 2 0.0000
633 BRADYCARDIA 2 0.0000
634 INJECTION SITE BRUISING 3 0.0000
635 INSOMNIA 10 0.0000
636 BLOOD BILIRUBIN INCREASED 1 0.0000
637 RASH PRURITIC 2 0.0000
638 RESPIRATORY ARREST 1 0.0000
639 RESPIRATORY DISTRESS 1 0.0000
640 DIVERTICULITIS 1 0.0000
641 INFLUENZA 4 0.0000
642 OXYGEN SATURATION DECREASED 2 0.0000
643 INTENTIONAL DOSE OMISSION 1 0.0000
644 RED BLOOD CELL COUNT DECREASED 1 0.0000
645 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
646 LABORATORY TEST ABNORMAL 1 0.0000
647 FEELING ABNORMAL 8 0.0000
648 APHASIA 1 0.0000
649 THERAPEUTIC RESPONSE DECREASED 2 0.0000
650 VERTIGO 2 0.0000
651 FEMUR FRACTURE 1 0.0000
652 NERVOUS SYSTEM DISORDER 1 0.0000
653 SWOLLEN TONGUE 1 0.0000
654 DYSPHAGIA 3 0.0000
655 METABOLIC ACIDOSIS 1 0.0000
656 HIP FRACTURE 1 0.0000
657 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
658 FEBRILE NEUTROPENIA 2 0.0000
659 FUNGAL INFECTION 1 0.0000
660 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
661 CHEST DISCOMFORT 3 0.0000
662 GASTRIC DISORDER 1 0.0000
663 INJECTION SITE REACTION 2 0.0000
664 HYPERKALAEMIA 1 0.0000
665 LYMPHADENOPATHY 1 0.0000
666 PLATELET COUNT DECREASED 3 0.0000
667 PRODUCT ADHESION ISSUE 1 0.0000
668 CEREBRAL HAEMORRHAGE 1 0.0000
669 CRYING 1 0.0000
670 HYPERGLYCAEMIA 1 0.0000
671 PANIC ATTACK 1 0.0000
672 EYE SWELLING 1 0.0000
673 HEPATIC FUNCTION ABNORMAL 1 0.0000
674 DYSARTHRIA 1 0.0000
675 HOT FLUSH 2 0.0000
676 CHRONIC KIDNEY DISEASE 2 0.0000
677 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
678 PLASMA CELL MYELOMA 1 0.0000
679 CHILLS 3 0.0000
680 DISORIENTATION 1 0.0000
681 DRUG INTERACTION 4 0.0000
682 CARDIAC FAILURE 2 0.0000
683 DEVICE BREAKAGE 1 0.0000
684 RHABDOMYOLYSIS 1 0.0000
685 WITHDRAWAL SYNDROME 1 0.0000
686 RENAL IMPAIRMENT 2 0.0000
687 MYALGIA 4 0.0000
688 HYPOACUSIS 1 0.0000
689 DEVICE LEAKAGE 1 0.0000
690 MENTAL DISORDER 1 0.0000
691 DRY SKIN 3 0.0000
692 PULMONARY OEDEMA 1 0.0000
693 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
694 THROAT IRRITATION 1 0.0000
695 NEUTROPENIA 3 0.0000
696 NEPHROLITHIASIS 1 0.0000
697 TINNITUS 1 0.0000
698 BREAST CANCER 2 0.0000
699 COGNITIVE DISORDER 1 0.0000
700 HEART RATE INCREASED 2 0.0000
701 LEUKOPENIA 1 0.0000
702 HYPOTENSION 4 0.0000
703 ACUTE KIDNEY INJURY 3 0.0000
704 HOSPITALISATION 3 0.0000
705 HAEMOGLOBIN DECREASED 2 0.0000
706 SPEECH DISORDER 1 0.0000
707 PANCREATITIS 1 0.0000
708 DISTURBANCE IN ATTENTION 1 0.0000
709 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
710 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
711 HAEMATOCHEZIA 1 0.0000
712 FLATULENCE 1 0.0000
713 URINARY TRACT INFECTION 3 0.0000
714 PALPITATIONS 2 0.0000
715 EMOTIONAL DISTRESS 2 0.0000
716 SUICIDE ATTEMPT 1 0.0000
717 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
718 BLOOD GLUCOSE INCREASED 3 0.0000
719 SWELLING FACE 1 0.0000
720 DEHYDRATION 2 0.0000
721 NEOPLASM MALIGNANT 1 0.0000
722 SKIN BURNING SENSATION 1 0.0000
723 OVERDOSE 3 0.0000
724 EPISTAXIS 1 0.0000
725 HALLUCINATION 1 0.0000
726 UNEVALUABLE EVENT 1 0.0000
727 INJECTION SITE HAEMORRHAGE 1 0.0000
728 CARDIAC FAILURE CONGESTIVE 1 0.0000
729 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
730 TOXICITY TO VARIOUS AGENTS 2 0.0000
731 SKIN EXFOLIATION 1 0.0000
732 BALANCE DISORDER 1 0.0000
733 MYOCARDIAL INFARCTION 2 0.0000
734 COVID-19 2 0.0000
735 DEVICE ISSUE 1 0.0000
736 NEUROPATHY PERIPHERAL 1 0.0000
737 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
738 ERYTHEMA 2 0.0000
739 THROMBOCYTOPENIA 1 0.0000
740 INCORRECT DOSE ADMINISTERED 2 0.0000
741 INJECTION SITE PAIN 2 0.0000
742 NO ADVERSE EVENT 1 0.0000